CPA4 and neoplasm: Subcutaneous tumour transplantation was performed in NCG mice (Fig. 6o), and the results showed that overexpression of CPA4 in HLZ01 cells could resist the tumour-killing effect of HGS-ETR1/2 (Fig. 6p).